blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4406981

EP4406981 - BLOOD CELL SEPARATING AGENT FOR ANALYSIS AND BLOOD CELL SEPARATION METHOD [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  27.06.2024
Database last updated on 02.11.2024
FormerThe international publication has been made
Status updated on  01.04.2023
Most recent event   Tooltip27.06.2024Publication in section I.1 EP Bulletinpublished on 31.07.2024  [2024/31]
27.06.2024Request for examination filedpublished on 31.07.2024  [2024/31]
Applicant(s)For all designated states
Nitto Boseki Co., Ltd.
1, Aza Higashi
Gonome
Fukushima-shi
Fukushima 960-8161 / JP
[2024/31]
Inventor(s)01 / MASUYA Amiko
Koriyama-shi, Fukushima 963-8061 / JP
02 / YABE Kazuho
Koriyama-shi, Fukushima 963-8061 / JP
03 / WATANABE Koji
Koriyama-shi, Fukushima 963-8061 / JP
04 / TERUUCHI Yuya
Koriyama-shi, Fukushima 963-8061 / JP
05 / TERUUCHI Yoko
Koriyama-shi, Fukushima 963-8061 / JP
 [2024/31]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2024/31]
Application number, filing date22872866.320.09.2022
[2024/31]
WO2022JP34889
Priority number, dateJP2021015292021.09.2021         Original published format: JP 2021152920
[2024/31]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2023048112
Date:30.03.2023
Language:JA
[2023/13]
Type: A1 Application with search report 
No.:EP4406981
Date:31.07.2024
Language:EN
[2024/31]
Search report(s)International search report - published on:JP30.03.2023
ClassificationIPC:C08F26/02, G01N33/48
[2024/31]
CPC:
G01N33/48 (EP); C08F226/02 (EP); G01N33/491 (EP)
C-Set:
C08F226/02, C08F226/04 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/31]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:MITTEL ZUR TRENNUNG VON BLUTZELLEN ZUR ANALYSE UND BLUTZELLENTRENNUNGSVERFAHREN[2024/31]
English:BLOOD CELL SEPARATING AGENT FOR ANALYSIS AND BLOOD CELL SEPARATION METHOD[2024/31]
French:AGENT DE SÉPARATION DES CELLULES SANGUINES POUR L'ANALYSE ET PROCÉDÉ DE SÉPARATION DES CELLULES SANGUINES[2024/31]
Entry into regional phase14.03.2024Translation filed 
14.03.2024National basic fee paid 
14.03.2024Search fee paid 
14.03.2024Designation fee(s) paid 
14.03.2024Examination fee paid 
Examination procedure14.03.2024Amendment by applicant (claims and/or description)
14.03.2024Examination requested  [2024/31]
Fees paidRenewal fee
31.03.2024Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]JP2007518978  ;
 [A]JP5510333B  ;
 [Y]WO2015046557  (SEKISUI MEDICAL CO LTD [JP]);
 [Y]WO2018066588  (DENKA SEIKEN KK [JP]);
 [YX]JP2019010328  (KAO CORP)
by applicantJPS5926062
 JP2016107100
 JP2018059791
 JP2019010328
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.